Published in Immunology on May 01, 1977
An examination of the cytotoxic effects of silica on macrophages. J Exp Med (1966) 8.42
Antibody in the induction and inhibition of lymphocyte cytotoxicity. Transplant Rev (1972) 4.79
Postoperative depression of the lymphocyte response to phytohaemagglutinin. Lancet (1967) 2.57
Polymorphonuclear leukocytes in antibody-dependent cellular cytotoxicity. J Immunol (1975) 1.98
Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease. Br Med J (1972) 1.84
The effect of anaesthesia on the lymphocyte response to phytohaemagglutinin. Clin Exp Immunol (1974) 1.37
Depression of lymphocyte responses after surgical trauma. Br J Exp Pathol (1973) 1.29
Effector cell activity in antibody mediated cell dependent immune lysis. II. Evidence for different populations of effector cells for different targets. Cell Immunol (1975) 1.16
Depression of immunological responses due to surgery. A model in the guinea-pig. Immunology (1974) 1.10
Lymphocyte transformation and changes in leukocyte count: effects of anesthesia and operation. Anesthesiology (1975) 1.01
Effect of surgery on tumour-directed leucocyte responses. Br Med J (1975) 0.99
The effect of halothane on phytohemagglutinin-induced transformation of human lymphocytes in vitro. Anesthesiology (1972) 0.91
Post-operative depression of antibody-dependent lymphocyte cytotoxicity following minor surgery and anaesthesia. Immunology (1976) 0.90
The effects of halothane on cultured mouse neuroblastoma cells. I. Inhibition of morphological differentiation. J Cell Biol (1974) 0.89
Anesthetic-induced transformation of axonal microtubules. J Cell Biol (1972) 0.87
Observations on the antibody-dependent cytotoxic cell by scanning electron microscopy. Clin Exp Immunol (1975) 0.83
Effects of anaesthetics on the mobility of Dictyostelium discoideum. Nat New Biol (1972) 0.82
Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration. Immunology (1992) 3.09
Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology (1995) 1.86
Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration. Immunology (1997) 1.76
Tumour necrosis factor-alpha-induced migration of human Langerhans cells: the influence of ageing. Br J Dermatol (2002) 1.59
Altered protein tyrosine phosphorylation in asthmatic bronchial epithelium. Eur Respir J (2005) 1.56
Dendritic cell accumulation in draining lymph nodes during the induction phase of contact allergy in mice. Int Arch Allergy Appl Immunol (1989) 1.55
Divergent immune responses to respiratory and contact chemical allergens: antibody elicited by phthalic anhydride and oxazolone. Clin Exp Allergy (1992) 1.54
Phenotypic characteristics of antigen-bearing cells in the draining lymph nodes of contact sensitized mice. Immunology (1990) 1.46
Lymphocyte cytotoxicity against autologous tumour biopsy cells in humans. Int J Cancer (1977) 1.45
T helper cell 2 immune skewing in pregnancy/early life: chemical exposure and the development of atopic disease and allergy. Br J Dermatol (2015) 1.43
MHC class II expression by Langerhans' cells and lymph node dendritic cells: possible evidence for maturation of Langerhans' cells following contact sensitization. Immunology (1991) 1.42
Human tumor-infiltrating lymphocytes: a marker of host response. Semin Hematol (1985) 1.38
Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4. J Immunol (1993) 1.38
Modulation of epidermal Langerhans' cell frequency by tumour necrosis factor-alpha. Immunology (1994) 1.33
Alpha 6 integrins are required for Langerhans cell migration from the epidermis. J Exp Med (1997) 1.32
Specific and non-specific lymphocyte cytotoxicity in colon carcinoma. Br J Cancer (1981) 1.31
Antigen-bearing dendritic cells in the draining lymph nodes of contact sensitized mice: cluster formation with lymphocytes. Immunology (1991) 1.31
Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes. J Mol Endocrinol (2005) 1.29
The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma. Clin Exp Allergy (2003) 1.25
The local lymph node assay: a viable alternative to currently accepted skin sensitization tests. Food Chem Toxicol (1996) 1.25
Natural cytotoxicity in humans: susceptibility of freshly isolatd tumor cells to lysis. J Natl Cancer Inst (1980) 1.24
Systemic migration of dendritic cells during contact sensitization. Immunology (1990) 1.24
Human tumour--lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour-infiltrating, blood and lymph-node lymphocytes with autologous tumour cells. Int J Cancer (1977) 1.24
Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours. Int J Cancer (1979) 1.22
Cytokines and Langerhans cell mobilisation in mouse and man. Cytokine (2005) 1.22
Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy. Allergy (2011) 1.20
Embryonic antigen expression on experimental rat tumours. Transplant Rev (1974) 1.20
Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization. Clin Exp Allergy (2005) 1.17
Embryonic antigen expression in chemically induced rat hepatomas and sarcomas. Int J Cancer (1972) 1.17
Further evaluation of the local lymph node assay in the final phase of an international collaborative trial. Toxicology (1996) 1.15
Assessment of the safety of foods derived from genetically modified (GM) crops. Food Chem Toxicol (2004) 1.11
Identification of dendritic cells as a major source of interleukin-6 in draining lymph nodes following skin sensitization of mice. Immunology (1995) 1.11
Induction of respiratory hypersensitivity to diphenylmethane-4,4'-diisocyanate (MDI) in guinea pigs. Influence of route of exposure. Toxicology (1994) 1.09
Langerhans cell migration. Clin Exp Dermatol (2000) 1.09
The effect of ultraviolet B irradiation and urocanic acid isomers on dendritic cell migration. Immunology (1992) 1.09
Role of tumour necrosis factor-alpha in ultraviolet B light-induced dendritic cell migration and suppression of contact hypersensitivity. Immunology (1994) 1.09
Why are some proteins allergens? Toxicol Sci (2000) 1.08
Assessment of the functional activity of antigen-bearing dendritic cells isolated from the lymph nodes of contact-sensitized mice. Int Arch Allergy Appl Immunol (1989) 1.05
Interleukin 1 beta and the stimulation of Langerhans cell migration: comparisons with tumour necrosis factor alpha. Arch Dermatol Res (1997) 1.04
The effects of ultraviolet radiation on the human immune system. Br J Dermatol (1999) 1.04
Intercellular adhesion molecule-1 (ICAM-1) expression by lymph node dendritic cells: comparison with epidermal Langerhans cells. Immunol Lett (1992) 1.04
Immunotoxicology: suppressive and stimulatory effects of drugs and environmental chemicals on the immune system. A discussion. Arch Toxicol (1989) 1.04
Human tumor-lymphocyte interaction in vitro. VI. Specificity of primary and secondary autologous lymphocyte-mediated cytotoxicity. J Natl Cancer Inst (1979) 1.03
IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: regulation by lactoferrin. Clin Exp Immunol (2003) 1.03
Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-alpha- and IL-1beta-dependent mechanism. Immunology (2001) 1.03
Human tumour antigens defined by cytotoxicity and proliferative responses of cultured lymphoid cells. Nature (1982) 1.03
A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses. J Appl Toxicol (1999) 1.03
The rapid rejection of allogeneic lymphocytes by a non-adaptive, cell-mediated mechanism (NK activity). Immunology (1985) 1.02
Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany. Cell Mol Life Sci (2011) 1.02
Tumour necrosis factor-alpha induces Langerhans cell migration in humans. Br J Dermatol (1999) 1.02
Extravascular natural cytotoxicity in man: Anti-K562 activity of lymph-node and tumour-infiltrating lymphocytes. Int J Cancer (1981) 1.01
Differential stimulation of immune function by respiratory and contact chemical allergens. Immunology (1991) 1.01
The bronchial epithelium in asthma--much more than a passive barrier. Monaldi Arch Chest Dis (2001) 1.00
Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J Immunol (2001) 0.99
Effect of surgery on tumour-directed leucocyte responses. Br Med J (1975) 0.99
In vitro generation of cytotoxicity against autologous human tumour biopsy cells. Int J Cancer (1978) 0.98
Interactions of IFN-gamma with IL-3 and IL-4 in the regulation of serotonin and arachidonate release from mouse peritoneal mast cells. Immunology (1994) 0.98
The Hapten-Atopy hypothesis II: the 'cutaneous hapten paradox'. Clin Exp Allergy (2011) 0.98
Intracellular phosphotyrosine induction by major histocompatibility complex class II requires co-aggregation with membrane rafts. J Biol Chem (1999) 0.97
Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: limiting dilution analysis in peripheral blood and at the tumour site. Int J Cancer (1982) 0.97
Specific T-cell-mediated killing of autologous lung tumour cells. Cell Immunol (1980) 0.95
Differential regulation by thalidomide and dexamethasone of cytokine expression in human peripheral blood mononuclear cells. Immunopharmacology (1998) 0.95
Detection of abnormal peripheral blood mononuclear cell cytokine networks in human IgA nephropathy. Kidney Int (1993) 0.94
Threshold for classification as a skin sensitizer in the local lymph node assay: a statistical evaluation. Food Chem Toxicol (1999) 0.94
Regulation of epidermal Langerhans cell migration by lactoferrin. Immunology (2000) 0.94
The expression of a phase-specific foetal antigen on rat embryo cells. Transplantation (1974) 0.94
The principles and practice of toxigenomics: applications and opportunities. Toxicol Sci (2000) 0.94
Characterization of a monoclonal antibody to cis-urocanic acid: detection of cis-urocanic acid in the serum of irradiated mice by immunoassay. Immunology (1993) 0.94
Specific cytotoxicity against autologous tumour and proliferative responses of human lymphocytes grown in interleukin 2. Int J Cancer (1982) 0.93
Langerhans cells require signals from both tumour necrosis factor alpha and interleukin 1 beta for migration. Adv Exp Med Biol (1997) 0.93
Tumour-reactive lymphocytes stimulated in mixed lymphocyte and tumour culture. Clonal analysis of effector cells in cytotoxic and proliferative assays. Cancer Immunol Immunother (1983) 0.92
Inhibition by dexamethasone of Langerhans cell migration: influence of epidermal cytokine signals. Immunopharmacology (1999) 0.92
Modulation of IL 2-dependent growth of mouse NK cells by interferon and T lymphocytes. J Immunol (1983) 0.92
Contribution of CD4+ and CD8+ T lymphocyte subsets to the cytokine secretion patterns induced in mice during sensitization to contact and respiratory chemical allergens. Immunology (1996) 0.92
Role of CD4(+) T helper 2-type cells in cutaneous inflammatory responses induced by fluorescein isothiocyanate. Immunology (2000) 0.92
Separation and characteristics of tumor-infiltrating lymphocytes in man. Contemp Top Immunobiol (1980) 0.91
Immunogenicity of embryonic antigens associated with chemically induced rat tumours. Int J Cancer (1974) 0.91
Local lymph node assay responses to paraphenylenediamine: intra- and inter-laboratory evaluations. J Appl Toxicol (1999) 0.91
Determination of protein allergenicity: studies in mice. Toxicol Lett (2001) 0.91
Post-operative depression of antibody-dependent lymphocyte cytotoxicity following minor surgery and anaesthesia. Immunology (1976) 0.90
Animal models of protein allergenicity: potential benefits, pitfalls and challenges. Clin Exp Allergy (2009) 0.90
Inhibition of CD23-dependent facilitated allergen binding to B cells following vaccination with genetically modified hypoallergenic Bet v 1 molecules. Clin Exp Allergy (2010) 0.90
Differentiation between the embryonic and tumour specific antigens on chemically induced rat tumours. Br J Cancer (1974) 0.90
Interleukin-1-induced interleukin-6 synthesis is mediated by the neutral sphingomyelinase/Src kinase pathway in neurones. Br J Pharmacol (2007) 0.89
The human mixed lymphocyte-tumor cell interaction test. I. Positive autologous lymphocyte proliferative responses can be stimulated by tumor cells as well as by cells from normal tissues. Cancer Immunol Immunother (1984) 0.89
Does hapten exposure predispose to atopic disease? The hapten-atopy hypothesis. Trends Immunol (2009) 0.89
Restricted autologous lymphocytotoxicity in lung neoplasia. Br J Cancer (1978) 0.89
Thalidomide: lack of mutagenic activity across phyla and genetic endpoints. Mutat Res (1997) 0.89
Exogenous interleukin-1beta restores impaired Langerhans cell migration in aged skin. Br J Dermatol (2004) 0.89
Leucocytotoxicity in malignant and non-malignant colonic diseases. Clin Exp Immunol (1975) 0.88
Strategies for identifying false positive responses in predictive skin sensitization tests. Food Chem Toxicol (1998) 0.88
Exogenous topical lactoferrin inhibits allergen-induced Langerhans cell migration and cutaneous inflammation in humans. Br J Dermatol (2001) 0.88
Differential function of dendritic cells isolated from blood and lymph nodes. Immunology (1994) 0.88
Differential regulation of mast cell cytokines by both dexamethasone and the p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580. Clin Exp Immunol (2004) 0.88
The cellular and molecular basis for divergent allergic responses to chemicals. Chem Biol Interact (1992) 0.88
Draining lymph node cell activation in guinea pigs: comparisons with the murine local lymph node assay. Toxicology (1991) 0.88
Classification of chemical allergens according to cytokine secretion profiles of murine lymph node cells. J Appl Toxicol (1997) 0.87
Cell-mediated cytotoxicity to human pulmonary neoplasms. Int J Cancer (1975) 0.87